A step-by-step guide for conducting safe and successful bile duct cannulated PK studies
In recent years, the biopharmaceutical industry has increasingly focused on reducing animal testing when conducting safety and efficacy studies for new drugs. Ethical considerations, regulatory guidelines, and advancements in alternative testing methods like artificial intelligence have driven this shift.
Bispecific antibodies: engineering complexity into simplicity
Clear guidance on bispecific antibodies, from formats and engineering to analytics and control strategy, for scalable development and manufacturing. Read now.
Integrated Expertise for Complex Modalities: Driving Innovation in Molecular Glue Discovery
Prove induced proximity in molecular glues with ITC, fluorescence polarization, and co-IP. Practical steps for stronger discovery decisions. Read the guide.
Translational and Clinical Research services
Syngene’s data consortium comprises a group of consenting clients working towards greater learning through predictive modeling to enable faster drug discovery.
GLP-certified viral testing and clearance services
Syngene offers GLP-certified viral testing and clearance services with flexible scheduling and rapid turnaround, supporting over 100 global clinical programs. Their facility is India’s only GLP-certified site for viral safety studies, ensuring compliance with FDA, EMA, and WHO regulations. Services include viral clearance studies, cell bank testing, and in-process/batch testing for biologics.
Plasmid, mRNA, & Viral Vector Manufacturing: Scaling for the Gene Therapy Boom
Explore how plasmid DNA, mRNA CDMO, and viral vector manufacturing are scaling to meet the rising demand of AAV gene therapy and genetic medicines. Read on to know more.
Integrated Innovation Partners: The Strategic Edge in Modern Drug Development
Publication: Pharmaceutical Technology Focus
Beyond timelines: How Syngene redefines customer-centric project management
Customer-centric pharma project management software for CRDMO programs—integrating metrics, feedback, and risk on one platform to deliver with speed and quality.
Translational Research at Syngene: From Discovery to Personalized Medicine
Syngene’s translational research speeds drug discovery and development and enables personalized medicine with robust models and biomarkers. Explore the approach.
Nitrosamine Assessment
Syngene offers comprehensive nitrosamine evaluation through mutagenicity testing, including Enhanced Ames, HPRT, and TK6 assays along with carcinogenic potency categorization (CPCA) to support regulatory‑compliant impurity risk assessment.